Company News
-
February 21, 2023
bioMérieux launches a PCR kit for detection of the monkeypox virus
bioMérieux has developed a MONKEYPOX R-GENE® PCR kit. Available for research use only (RUO), this kit can easily be used by laboratories around the world. -
February 02, 2023
bioMérieux Introduces GENE-UP® ENVIROPRO™
bioMérieux, a world leader in in vitro diagnostics, announces the availability of GENE-UP® ENVIROPRO™, the only assay of its kind to simultaneously detect both Salmonella and Listeria from environmental swabbing, including PCR confirmation.
-
January 17, 2023
18 Top Employer certifications for bioMérieux!
These certifications demonstrate the quality of our HR strategy and rewards the commitment of our HR teams who work every day to improve the employee experience at bioMérieux! The Top Employer seal also impacts our attractiveness by telling candidates that we care about our people! -
January 04, 2023
bioMérieux establishes Antimicrobial Stewardship Centers of Excellence
bioMérieux takes a proactive, partnership-driven approach to combating AMR with diagnostic and data-driven solutions to improve stewardship efforts. To further this goal, bioMérieux created the AMS Centers of Excellence (CoE) designation awarded to hospitals around the world as a sign of a joint commitment to best AMS practices. -
December 08, 2022
Cell and Gene Therapies: bioMérieux partners with NecstGen
bioMérieux and NecstGen, collaborate to accelerate the development of Cell and Gene Therapies (CGT) through the provision of ‘state of the art’ and rapid quality and safety testing technologies that will allow safe and effective advanced therapeutics production.
Follow us on Socials for more news!